Pain News and Research

Latest Pain News and Research

Clinical study: Celecoxib drug may treat breast cancer

Clinical study: Celecoxib drug may treat breast cancer

Cosmofrance introduces Dermasculpt microcannula for painless cosmetic injections

Cosmofrance introduces Dermasculpt microcannula for painless cosmetic injections

Nation's emergency physicians warn about dangers linked with deep vein thrombosis

Nation's emergency physicians warn about dangers linked with deep vein thrombosis

Olympic Gold Medalist, P.A.D. Coalition raise awareness about peripheral arterial disease

Olympic Gold Medalist, P.A.D. Coalition raise awareness about peripheral arterial disease

Heart bypass surgery rates fall by 38% between 2001 and 2008: Study

Heart bypass surgery rates fall by 38% between 2001 and 2008: Study

Researchers develop novel spinal cord injury treatment

Researchers develop novel spinal cord injury treatment

Techne acquires Tocris Holdings

Techne acquires Tocris Holdings

New study: Text-heavy labels can reduce acetaminophen overdose

New study: Text-heavy labels can reduce acetaminophen overdose

Sports-specialization can increase risk of injuries in young athletes

Sports-specialization can increase risk of injuries in young athletes

Scientists discover new gene underlying angle-closure glaucoma

Scientists discover new gene underlying angle-closure glaucoma

Merck's Phase III study shows efficacy results of tafluprost to treat ocular hypertension

Merck's Phase III study shows efficacy results of tafluprost to treat ocular hypertension

New insight into itch and pain

New insight into itch and pain

Hyponatremia linked to high risk of fractures in elderly patients

Hyponatremia linked to high risk of fractures in elderly patients

Hebei Aoxing Pharma receives Chinese patent for naloxone sublingual film

Hebei Aoxing Pharma receives Chinese patent for naloxone sublingual film

Sorin introduces new VascuClear device for clinicians

Sorin introduces new VascuClear device for clinicians

Teva signs definitive agreement to acquire Cephalon shares for $6.8 billion

Teva signs definitive agreement to acquire Cephalon shares for $6.8 billion

VA develops FATE survey to access treatment quality at the end of patients' lives

VA develops FATE survey to access treatment quality at the end of patients' lives

OU-COM receives Osteopathic Heritage Foundation grant to address healthcare issues

OU-COM receives Osteopathic Heritage Foundation grant to address healthcare issues

Porter Adventist Hospital introduces new institute for robotic surgery

Porter Adventist Hospital introduces new institute for robotic surgery

Many herbal medicines banned under EU directives

Many herbal medicines banned under EU directives

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.